Skip to main content

BML Capital Management, LLC

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1616824 ZIONSVILLE, IN

Position in ACRS

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$53,437,500
+$10,545,000 QoQ
Shares Held
14,250,000
0.0% QoQ
Ownership
10.2%
of shares outstanding
% of Portfolio
34.38%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

BML Capital Management, LLC holds $125,623,464 across 10 Biotechnology names. ACRS ranks #1 (42.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ACRS
Aclaris Therapeutics, Inc.
This page
14,250,000 $53,437,500

All Filings in ACRS

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $53,437,500 14,250,000
2025-12-31 $42,892,500 14,250,000
2025-09-30 $27,075,000 14,250,000
2025-06-30 $20,235,000 14,250,000
2025-03-31 $21,802,500 14,250,000
2024-12-31 $35,340,000 14,250,000
2024-09-30 $16,387,500 14,250,000
2024-06-30 $14,286,947 12,988,134
2024-03-31 $11,650,958 9,395,934
2023-12-31 $685,762 653,107